Agendia

US: +1(786) 218-3810

Agendia is part of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients.

We know cancer is a genetic disease. Without understanding the genetics of a tumor, you can’t treat it. Knowing this, we developed an advanced genomics platform for tumor gene expression profiling and built microarray assay tests that can determine whether an individual patient is at high or low risk for breast or colon cancers recurrence, helping physicians more accurately tailor cancer treatments.

Agendia’s technology allows continuous transformation to grow product profile into new areas and information by listening, adapting and learning about the always changing biology of cancer.

Agendia offers a variety of breast cancer assays

to help personalize the patient's treatment by looking at what their likelihood of recurrence truly is.